Circulating Immune Complexes and Platelet Thromboxane Synthesis in Patients with Insulin-dependent (Type I) Diabetes Mellitus
Abstract
Platelets from diabetic subjects with circulating immune complexes (CIC) synthesized greater amounts of thromboxane than did platelets from CIC-negative patients or controls. In view of the known action of CIC on platelet function, a relationship between these two factors may be suggested in the initiation and progression of microangiopathy in diabetes.
- Received February 18, 1983.
- Revision received January 4, 1984.
- Accepted January 4, 1984.
- Copyright © 1984 by the American Diabetes Association
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this Issue
August 1984, 33(8)
Circulating Immune Complexes and Platelet Thromboxane Synthesis in Patients with Insulin-dependent (Type I) Diabetes Mellitus
